Entero Healthcare Solutions (NSE:ENTERO) EBIT: ₹2,337 Mil (TTM As of Mar. 2026)


NSE:ENTERO Entero Healthcare Solutions Ltd NSE:ENTERO
43 GF Score
Price ₹1,200.10
! 2 Warning Signs
View Full Analysis

What is Entero Healthcare Solutions EBIT?

Entero Healthcare Solutions NSE:ENTERO +1.67% 43 EBIT is ₹2,337 Mil as of Mar. 2026. GuruFocus rates NSE:ENTERO with a GF Score™ of 43/100. The stock has 2 warning signs investors should review.

Entero Healthcare Solutions's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was ₹753 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹2,337 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Entero Healthcare Solutions's annualized ROC % for the quarter that ended in Mar. 2026 was 8.75%. Entero Healthcare Solutions's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 23.68%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Entero Healthcare Solutions's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 4.14%.


Entero Healthcare Solutions  (NSE:ENTERO) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Entero Healthcare Solutions's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=2850 * ( 1 - 22.12% )/( (0 + 25369.27)/ 1 )
=2219.58/25369.27
=8.75 %

where

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=36002.63 - 7409.01 - ( 3224.35 - max(0, 15875.7 - 25084.36+3224.35))
=25369.27

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Entero Healthcare Solutions's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=3010.32/( ( (0 + max(0, 0)) + (2004.1 + max(10706.44, 0)) )/ 1 )
=3010.32/( ( 0 + 12710.54 )/ 1 )
=3010.32/12710.54
=23.68 %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 0) - (0 + 0 + 0)
=0

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(12124.42 + 8416.77 + 1318.82) - (7409.01 + 0 + 3744.56)
=10706.44

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Entero Healthcare Solutions's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=2337.18/56418.569
=4.14 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Entero Healthcare Solutions EBIT Related Terms


Entero Healthcare Solutions EBIT Historical Data

* Premium members only.

The historical data trend for Entero Healthcare Solutions's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Entero Healthcare Solutions EBIT Chart

Entero Healthcare Solutions Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
EBIT
Get a 7-Day Free Trial 62.84 407.12 960.37 1,803.61 2,337.21

Entero Healthcare Solutions Quarterly Data
Mar21 Mar22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 477.13 470.27 570.23 544.10 752.58

NSE:ENTERO vs MCK, CAH, COR: EBIT Comparison

For the Medical Distribution subindustry, Entero Healthcare Solutions's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Entero Healthcare Solutions EV-to-EBIT vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Entero Healthcare Solutions's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Entero Healthcare Solutions's EV-to-EBIT falls into.


NSE:ENTERO
43GF Score
Entero Healthcare Solutions Ltd NSE:ENTERO
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Entero Healthcare Solutions EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹2,337 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of ₹2,337 Mil mean?
Entero Healthcare Solutions (NSE:ENTERO) has a EBIT of ₹2,337 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Entero Healthcare Solutions.
Is Entero Healthcare Solutions' EBIT too high?
Entero Healthcare Solutions' current EBIT is ₹2,337 Mil. Overall, Entero Healthcare Solutions has a GF Score™ of 43/100, reflecting its overall financial health beyond just this single metric.
How does Entero Healthcare Solutions' EBIT compare to MCK and CAH?
Entero Healthcare Solutions' EBIT of ₹2,337 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Medical Distribution company?
A good EBIT depends on the Medical Distribution industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Entero Healthcare Solutions. Entero Healthcare Solutions's current EBIT is ₹2,337 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Entero Healthcare Solutions stock overvalued right now?
Entero Healthcare Solutions (NSE:ENTERO) has a current EBIT of ₹2,337 Mil. The current EBIT is ₹2,337 Mil. Entero Healthcare Solutions' overall GF Score™ is 43/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Entero Healthcare Solutions (NSE:ENTERO), the current EBIT is ₹2,337 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Entero Healthcare Solutions Business Description

Other Exchanges 544122:India
Address Bandra Kurla Complex, Trade Centre, Unit No. 605 & 606, 6th Floor, Bandra East, Mumbai, MH, IND, 400051
Entero Healthcare Solutions Ltd is a healthcare products distributor in India. It is involved in the business of distribution and marketing of pharmaceutical and surgical products and allied services. Geographically, the company derives a majority of its revenue from the domestic market.
43GF Score

Get the complete analysis for NSE:ENTERO

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,200.10
Price